Women's trials: the approval of the first oral contraceptive pill in the United States and Great Britain.
Junod
Suzanne White
SW
FDA History Office, HFC-24, Room 13-51, Rockville, MD, USA. sjunod@ora.fda.gov
Marks
Lara
L
D003276:Contraceptives, Oral / Q000009:adverse effects / Q000266:history; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects / Q000266:history*; D017277:Drug Approval / Q000266:history*; D045166:Estradiol Congeners / Q000009:adverse effects / Q000266:history*; D005260:Female; D049673:History, 20th Century; D006801:Humans; D008656:Mestranol / Q000009:adverse effects / Q000266:history*; D009641:Norethynodrel / Q000009:adverse effects / Q000266:history*; D006113:United Kingdom; D014481:United States; D014486:United States Food and Drug Administration / Q000266:history; D016387:Women's Health
D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D045166:Estradiol Congeners; C008124:Infecundin; D009641:Norethynodrel; D008656:Mestranol